More articles from From the Editor
- It’s time for a little history of medicine—introducing a new feature in CCJM
This month, we debut a feature focused on topics in the history of medicine, authored by Cleveland Clinic rheumatologist Adam Brown, MD.
- Continuous glucose monitoring: High-tech devices still need some low-tech backup
High-end devices that monitor patients’ physiology offer many benefits, but device malfunctions and disruptions are not rare events.
- Abdominal pain without physical findings is not always without physical cause
Mesenteric ischemia is a serious clinical entity characterized by a disconnect between the patient’s symptoms and the physical examination.
- Foxglove, not quite gone or forgotten
Digoxin use has waned dramatically over the past decades, with good reason, but for select patients, it may be a very reasonable option.
- SGLT-2 inhibitors: Diabetes and CKD and CHF (and gout?), oh my!
What mechanisms might account for the diverse beneficial effects of the SGLT-2 inhibitors observed across various diseases?
- Pursuing the diagnosis of low back pain
The recommended conservative approach eschewing initial imaging in patients with acute or subacute low back pain is unlikely to miss a significant clinical problem in those with no “red flags,” though the evaluation should be tempered in patients with chronic low back pain.
- New CCJM faces and features
Hospitalist James Pile, MD, and nephrologist George Thomas, MD, join the Journal staff as deputy editors.
- Corticosteroids: Giving and taking away
Two articles this month highlight opposite ends of the treatment spectrum, one on introducing adjunctive corticosteroids when treating Pneumocystis pneumonia, and the other on syndromes associated with glucocorticoid withdrawal.
- A tale of scale: Corticosteroids and pustular psoriasis
Guidelines and textbooks have recommended caution when using and withdrawing corticosteroids in patients with psoriasis, yet strong evidence that defines this association is hard to come by.
- Dealing with the “T” (testosterone)
If a patient feels better when taking testosterone supplementation, is it the “T” or is it a placebo effect?